Effect of malaria on placental volume measured using three-dimensional ultrasound: a pilot study. by Rijken, MJ et al.
RESEARCH Open Access
Effect of malaria on placental volume measured
using three-dimensional ultrasound: a pilot study
Marcus J Rijken1*, William E Moroski1, Suporn Kiricharoen1, Noaeni Karunkonkowit1, Gordon Stevenson2,
Eric O Ohuma3, J Alison Noble2, Stephen H Kennedy3, Rose McGready1,4,5, Aris T Papageorghiou3 and
François H Nosten1,4,5
Abstract
Background: The presence of malaria parasites and histopathological changes in the placenta are associated with
a reduction in birth weight, principally due to intrauterine growth restriction. The aim of this study was to examine
the feasibility of studying early pregnancy placental volumes using three-dimensional (3D) ultrasound in a malaria
endemic area, as a small volume in the second trimester may be an indicator of intra-uterine growth restriction
and placental insufficiency.
Methods: Placenta volumes were acquired using a portable ultrasound machine and a 3D ultrasound transducer
and estimated using the Virtual Organ Computer-aided AnaLysis (VOCAL) image analysis software package. Intra-
observer reliability and limits of agreement of the placenta volume measurements were calculated. Polynomial
regression models for the mean and standard deviation as a function of gestational age for the placental volumes
of uninfected women were created and tested. Based on these equations each measurement was converted into a
z -score. The z-scores of the placental volumes of malaria infected and uninfected women were then compared.
Results: Eighty-four women (uninfected = 65; infected = 19) with a posterior placenta delivered congenitally
normal, live born, single babies. The mean placental volumes in the uninfected women were modeled to fit 5th,
10th, 50th, 90th and 95th centiles for 14-24 weeks’ gestation. Most placenta volumes in the infected women were
below the 50th centile for gestational age; most of those with Plasmodium falciparum were below the 10th centile.
The 95% intra-observer limits of agreement for first and second measurements were ± 37.0 mL and ± 25.4 mL at
30 degrees and 15 degrees rotation respectively.
Conclusion: The new technique of 3D ultrasound volumetry of the placenta may be useful to improve our
understanding of the pathophysiological constraints on foetal growth caused by malaria infection in early
pregnancy.
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Background
Falciparum and vivax malaria have a markedly negative
impact on mothers and babies [1,2]. For example, malaria
infection in pregnancy is associated with a reduction in
birth weight, principally due to intrauterine growth restric-
tion (IUGR)[3,4]. Although the mechanisms responsible
for IUGR are not fully understood, histopathological
changes, such as thickening of basal membranes of the
placenta[5], intervillositis[6-9], hypoxia[10,11] and syncy-
tial destruction [12,13] have all been implicated.
The introduction of three-dimensional (3D) ultrasound
has made it possible to assess intrauterine growth more
accurately by allowing foetal organ and placental volumes
to be measured [14,15]. For example, a small placental
volume in the second trimester may be an indicator of
IUGR and placental insufficiency [16,17]. Virtual Organ
Computer-aided AnaLysis (VOCAL™, General Electric
(GE) Healthcare, Austria) is a software analysis package
used for calculating volumetry of different organs, such
as the placenta [18], foetal volume [19] and organs
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including the foetal brain [20], thigh [21], spleen [22] and
lungs [23].
This relatively new technique has never been used to
study placenta volumes in pregnancies complicated by
malaria. The aim of this study was to examine the feasi-
bility of studying early pregnancy placental volumes in a
malaria endemic area.
Methods
The participants in the present study were attending the
antenatal clinic (ANC) at Shoklo Malaria Research Unit
(SMRU), which is located on the Thai-Burmese border.
SMRU has focused on the epidemiology, prevention and
treatment of malaria in pregnancy since 1986. The epide-
miology of Plasmodium (P.) falciparum [24] and P. vivax
[25] malaria in pregnancy is well described. There is a lack
of effective prevention strategies and the malaria parasites
are multi-drug resistant. Hence, SMRU runs an ANC pro-
gramme with weekly screening to detect and treat all para-
sitaemic episodes during pregnancy to prevent maternal
deaths [24]. All women are encouraged to attend the ANC
as early as possible in pregnancy and to deliver at SMRU
under the care of Advance Life Support in Obstetrics
(ALSO) trained midwives and doctors; those requiring Cae-
sarean section are transferred to the nearest Thai hospital.
The study was part of a larger foetal growth project
(ClinicalTrials.gov Identifier: NCT00840502), approved
by the Ethics Committees of Oxford (OxTREC (14-08))
and Mahidol (TMEC 2008-028) Universities.
Ultrasonography
Ultrasound scans were performed trans-abdominally
using a Voluson i (GE Healthcare, Austria) with a RAB2-
5-RS; 2-5 MHz/Real time 3D probe. The machine was
housed in a dedicated air-conditioned room equipped
with a voltage stabilizer. All scans were obtained by sono-
graphers specifically trained in foetal growth scanning
[26], with regular internal quality control at SMRU; in
addition, images were regularly sent for external quality
control to the INTERGROWTH-21st Project team at the
University of Oxford [27].
Only women with singleton pregnancies were recruited.
As the last menstrual period is largely unknown in this
population [26], gestational age (GA) was determined by
measuring the foetal Crown Rump Length (CRL) between
9+0 and 13+6 weeks. The protocol and operating manual
for obtaining CRL measurements were similar to those
used in the International Fetal and Newborn Growth Con-
sortium for the 21st Century (INTERGROWTH-21st)
Project[27]. Briefly, using three separate images, three
blinded measurements were taken of each CRL; the mean
of the three values was then used to estimate GA using
Robinson’s charts [28].
Thereafter, women were invited to attend for a foetal
growth scan every 5 weeks until delivery to take standard
2D foetal biometric measurements. If a woman did not
attend a scheduled scan then she was scanned at the next
available opportunity. Every woman with a malaria epi-
sode detected by peripheral smear was treated using
WHO protocols [29] and had foetal growth scans (in
addition to those planned) at the time of a positive smear
and 2 weeks later.
After standard 2D measurements were taken, a 3D
sweep was obtained through the placenta. The 3D placen-
tal volume was acquired keeping the probe perpendicular
to the placental plate and the size of the volume box was
adapted to include the entire placenta. The sweep angle
was set at 85° so as to visualize the maximum amount of
placenta possible. Care was taken to minimize movement
artifact. Once the scan was complete, volume data were
stored on the system’s hard drive for later analysis.
Analysis
Only 3D ultrasound images of the placenta on the poster-
ior uterine wall taken between 14+0 to 23+6 weeks (two
sets of five weeks) were analysed. This approach was cho-
sen because most placentas (especially on the anterior
wall) are too large to fit in a single 3D sweep after
20 weeks. Based on published recommendations for cross-
sectional studies, only one measurement per woman was
included in the analysis [30,31]; if more than one good
quality volume scan was available, the last one was ana-
lysed. Women who miscarried, and those with early onset
pre-eclampsia or who left the study area before birth, were
excluded. Scans were excluded from the analysis if the
image quality was poor or a single continuous outline
could not be drawn around the placenta as accurate
volume data could not be obtained in these circumstances.
One author (WEM), blinded to clinical data, per-
formed the volume measurements using the VOCAL™
method as described by Wegrzyn et al [32]. A sequence
of sections of the placenta was obtained with the
VOCAL™ method, which is based on the rotation of an
object along its axis, using a predefined angle. Each pla-
cental volume was calculated with fixed angles of 30°
(six sections) and 15° (12 sections). All volume measure-
ments were taken twice for both rotation angles and an
average of the 2 volume measurements was computed
for each rotation to be used in the analysis.
Intra-observer reliability and limits of agreement
(mean difference ± 1.96 SD) of the placenta volume
measurements were calculated as described by Bland
and Altman [33]. Systemic bias was determined by cal-
culating the 95% confidence intervals (CI) for the mean
difference between the measurements. If zero was
included within this interval, no bias was assumed.
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From the 15° measurements, separate polynomial
regression models were fitted for the mean and standard
deviation (SD), each as a function of GA [30], of the
placenta volumes of women who had not been infected
with malaria prior to the volume scan. This approach
assumes that the distribution of measurements at each
GA is Gaussian. The models were examined under the
family of fractional polynomials utilizing its wide range
of possibilities and flexibility [34]. An iterative procedure
implemented in STATA version 11 statistical software
(StataCorp, TX, USA) was used, whereby the model for
the mean is weighted by the reciprocal of the square of
the fitted SD [35]. A goodness-of-fit test of the models
was also assessed by a likelihood ratio test by comparing
the deviances. The estimated equations for the mean
and the SD of these placenta volumes were of the form
y = a + b*GA (where GA is in days). From these predic-
tive mean and SD equations the corresponding centiles
were calculated using the formula:
centile = mean + K ∗ SD,
where K is the corresponding centile from the theoreti-
cal Gaussian distribution (e.g. determination of the 10th
and the 90th centiles requires K to be ± 1.28, and ± 1.645
for the fifth and 95th centiles).
Based on these equations the placental measurements
of all women were converted into a z-score:
z − score = measured volume − expected volume / SD volume.
The advantage of using z-scores is that it eliminates
the variability of measurements by GA, which allows for
direct comparability of measurements. A negative z-
score denotes a placental volume that is smaller than
the expected mean for the population at a given GA.
The z-scores of women who were or were not infected
with malaria before the scan were compared.
Clinical data were entered using Microsoft Access, and
analysed using SPSS version 15.0 for Windows (SPSS
Inc., Chicago Ill, USA) and STATA version 11. The stu-
dent’s t-test was used to compare means, the Shapiro-
Wilk test-to-test normality.
Results
Between 10 February 2009 and 30 April 2010, a total of
250 women were recruited at a mean gestational age of
80 ± 10 (SD) days. Of these women, 84 (33.6%) were eli-
gible for placental volume analysis as defined in the
Methods section (Figure 1). Their baseline characteris-
tics, e.g. age, parity, smoking status, etc., did not differ
from the non-included women (data not shown). Of
these 84 women, 19 (22.6%) had a malaria episode before
the volume scan; the other 65 women remained malaria
free (Table 1). All women delivered congenitally normal,
live born, single babies.
Measurement variability
For this part of the analysis the volume of all placentas (n
= 96 women, see Figure 1) were included irrespective of
birth outcome or malaria status. The difference between
the first and second measurements and the different rota-
tion angles on the same 3D volume were normally dis-
tributed. There was no significant difference between the
mean placental volumes for a single measurement at 30°
and 15°, p = 0.27. The mean difference between the two
measurements was 6.6 (95% CI: 3.6-9.70) mL at 30°, and
2.5 (95% CI: 0.3-4.6) mL at 15°. The 95% intra-observer
limits of agreement for first and second measurements
were ± 37.0 mL at 30° and ± 25.4 mL at 15° (Figure 2).
Placental volumes in uninfected women
The fractional polynomial linear regression model
yielded the following formulae:
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Figure 1 Inclusion of placental scans.
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a) Mean volume = - 162.83 + 3.60 × GA
b) SD = - 41.55 + 0.80 × GA
A simple linear model with no quadratic or cubic
terms for both the mean and SD provided the best fit
for the model with a deviance of 717.98. The z-scores
from the model did not suggest any deviation from nor-
mality using the Shapiro-Wilk test, p = 0.36.
Malaria
Nineteen women were infected with malaria between the
dating and placental volume scans: four (21%) with P. fal-
ciparum and 15 (79%) with P. vivax. The baseline charac-
teristics of infected and uninfected women were similar,
except for a lower mean haematocrit at the time of the
volume scan, as expected following infection with malaria:
31.2 ± 2.7% versus 32.6 ± 2.8% respectively, p = 0.05
(Table 1). The median number of malaria episodes was
one [range 1-4]. Four women had more than one malaria
episode in this period: three women had multiple P. vivax
episodes (four, two and two episodes), and one woman
had one P. vivax and one P. falciparum episode and was
classified as P. falciparum. The median time between the
last episode of malaria and the volume scan was 29 (IQR
14-42, range 0-59) days and this was not different for the
P. falciparum malaria or P. vivax malaria group. Figure 3
illustrates the model fit to the raw data for each measure-
ment with the fifth, 10th, 50th, 90th and 95th centiles for
placenta volumes between 14+0 and 23+6 weeks obtained
from the uninfected women (green dots). Most of the pla-
cental volumes of the infected women as a whole were
below the 50th centile; most of those with P. falciparum
were below the 10th centile (Figure 3).
Placental volume z-scores
The mean z-scores were similar in women when com-
pared for smoking status, gravidity, age, anaemia (hae-
matocrit < 30%) and those who had other infections in
pregnancy (Table 2). However, the difference was signif-
icant for women with P. falciparum infections, p =
0.003 (Table 2 and Figure 3). The z-scores could not be
related to the number of malaria episodes or symptoms
because of the small numbers involved.
Discussion
This pilot study demonstrates the feasibility of a) relating
placental volume to gestational age between 14 and 24
weeks in a malaria endemic area, and b) comparing
volumes between women with and without malaria. The
findings are important because measurement of placental
Table 1 Baseline characteristics of women
Malaria
(N = 19)
Non malaria
(N = 65)
Age (years) 25.1 ± 5.3 27.6 ± 7.0
Teenager, n (%) 3 (16) 7 (11)
Gravida 2 [1-7] 3 [1-14]
Parity 1 [0-5] 1 [0-13]
Primigravida 6 (32) 25 (29)
Smoking 4 (21) 11 (17)
Height (cm) 152 ± 5 153 ± 4
Hct at time of
ultrasound (%)
31.2 ± 2.7 32.6 ± 2.8
HBP or PE 3 (16) 5 (8)
Non-malarial infection 3 (16)* 6 (9)#
Data are presented as median [range], mean ± SD, or n (%)
HBP high blood pressure, Hct Haematocrit, PE pre-eclampsia, SD standard
deviation
* dysentery (32 weeks), pneumonia (24 weeks), suspected scrub typhus
(8 weeks)
# pneumonia (39 weeks), pyelonephritis (20 weeks), suspected scrub typhus
(3 cases; 25, 26 and 40 weeks), unspecified sepsis (36 weeks)
Mean = -6.6 mL
+1.96SD = 30.3 mL
-1.96SD = -43.6 mL
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Figure 2 Intra-observer variability of placental volume
measurements. Plot of difference against mean for intra-observer
variability of 145 placental volume measurements in 96 women
using VOCAL ™ at 15° (A) and 30° (B) rotational angles, with mean
difference and 95% limits of agreement indicated.
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volume in the first or second trimester may predict which
pregnancies are at high-risk of adverse outcomes
[17,36-38].
A variety of 2D and 3D ultrasound methods to measure
placental volume have been reported [32,36,39,41] but, in
clinical practice, 3D may be more accurate than 2D
methods [36]. VOCAL™, one commercially available
method of analysing 3D images, is considered relatively
fast and reproducible. It allows the borders of the target
organ to be modified after volumetric calculations and it
is superior to other methods in evaluating very irregularly
shaped structures, such as the placenta [42]. However,
accurate 3D volume measurement of the whole placenta
is only possible in the first half of pregnancy because the
volume seen is limited by the transducer footprint [36].
Accuracy is also influenced by the rotation angle of the
analysis method. In this study, a small error was observed
between the volume measurements when comparing the
two rotation methods, 30° and 15° (Figure 2). The 30° rota-
tion method resulted in a wider range of intra-observer
95% limits of agreement than the 15° method. Differing
reproducibility data have been reported for 3D measure-
ments and analyses of placental volume, varying from
0
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Figure 3 Placental volume centiles with placental volumes of women with falciparum and vivax malaria. Fitted the fifth and 95th (blue
lines), 10th and 90th (red lines) and 50th (green line) centile curves on the placental volumes of women without malaria or adverse birth
outcomes (green dots) and superimposed the placental volumes of women with Plasmodium falciparum malaria (blue diamonds) or Plasmodium
vivax malaria (red triangles).
Table 2 Risk factors associated with placental volume:
z-scores
N (%) Z-score
Mean ± SD
P-value
Smoking Yes 15 (18) 0.00 ± 1.1 0.73
No 69 (82) -0.11 ± 1.0
Primigravida Yes 31 (37) -0.14 ± 1.1 0.72
No 53 (63) -0.06 ± 1.0
Non-malarial infection Yes 9 (11) -0.14 ± 0.55 0.80
No 75 (89) -0.08 ± 1.1
Anaemia Yes 16 (19) -0.38 ± 0.86 0.16
No 68 (81) -0.02 ± 1.1
Teenager Yes 10 (12) 0.09 ± 1.5 0.70
No 74 (88) -0.11 ± 1.0
Malaria* Yes 19 (23) -0.38 ± 1.0 0.17
No 65 (77) 0.00 ± 1.0
P. falciparum* Yes 4 (6) -1.30 ± 0.4 0.003
No 65 (94) 0.00 ± 1.0
P. vivax* Yes 15 (19) -0.13 ± 1.0 0.66
No 65 (81) 0.00 ± 1.0
*occurring between the CRL dating and volume scans
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relatively poor to highly similar intra-and inter-observer
agreement [39,42-46]]. The results of this study are similar
to those of Cheong et al, who reported that measurements
made with VOCAL 30°, in an ex-vivo experiment, were
faster to complete, but associated with significantly higher
variability than those made with VOCAL 12° [18].
As in studies of foetal organ volumetry [19], placental
studies show wide discrepancies in reference ranges
[36]. The volumes reported in this study seem larger
than previously published data [17,36,38,40,41,45].
Rather than indicating true biological differences
between populations, the discrepancies are more likely
due to methodological differences; for example, in defin-
ing the placental border. Hence, there is a clear need to
standardize 3D volumetric methods, and definitions of
imaging planes and anatomical landmarks in particular.
In the absence of standardized methods, this dataset was
not compared with previously published placental
volumes; rather, the focus was on studying the effect of
malaria within the same population using a single set of
well-defined methods.
In this preliminary investigation, infection with
P. falciparum before 24 weeks’ gestation appears to be
associated with smaller placental volumes. In other
studies, principally in developed countries, early pla-
cental volumetry has been shown to predict IUGR and
adverse pregnancy outcomes [47,48], due probably to
impaired trophoblast invasion; in addition, small pla-
centas in the first trimester are associated with high
resistance uterine perfusion in the second trimester
[49]. All these factors have previously been related to
malaria in pregnancy as well [1,50,51].
Infection with P. vivax did not seem to be related to
placenta volume. The mechanisms underlying the
adverse effects of P. vivax malaria in pregnancy are not
fully understood [25,52,53]. Systemic or hormonal
mechanisms may play a role in P. vivax-related growth
restriction, as there is very little evidence that P. vivax
sequesters in the placenta, as P. falciparum does [53].
There was a borderline difference in haematocrit at the
time of the placental volume scan between the groups
(Table 1), however anaemia was not related to placenta
volume in the logistic regression model (Table 2). The
timing of anaemia in pregnancy and the effect on placental
weight and volume [1] needs further investigation.
This study, therefore, suggests that 3D placental volu-
metry is worthy of further investigation, in order to
assess whether IUGR related to malaria is mediated via
a smaller placental volume.
The data presented here involve small numbers and
should be interpreted cautiously. Another limitation of the
study was the initial decision to include only placentas on
the posterior wall to maximize the likelihood of capturing
the whole target organ in the volume sweep. This enabled
the inclusion of complete placental volumes up until
24 weeks’ gestation, but resulted in a large group of
women with an anterior placenta being excluded (n = 133,
Figure 1). The data used in this study may not be compar-
able with other populations because of the methodological
differences described above. Lastly, no inter-observer
variability analysis was available [19] but, for the purpose
of this analysis, which compared volumes measured by a
single observer using the same methods, this was not a
vital constraint.
Generally, ultrasound machines with 3D measurement
capacity are delicate, expensive, and require a high level
of technical skills and are therefore not available in
most malaria endemic areas. Nevertheless, the sugges-
tion that malaria in early pregnancy reduces placental
volume in the second trimester should be confirmed by
prospective studies evaluating volumes in relation to
foetal growth and adverse pregnancy outcomes. Such
studies should also allow for better assessment of poten-
tial confounders (such as maternal anaemia [1,54],
smoking [55] and parental anthropometry [56]). These
are essential steps in unravelling the sequence of events
from maternal malaria infection to IUGR.
In conclusion, the new technique of 3D ultrasound
volumetry of the placenta may be useful to improve our
understanding of the pathophysiological constraints on
foetal growth caused by malaria infection in early
pregnancy.
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